Solution
Industries
Resources
About
Beacon Search

ALSTEM

Company Snapshot

Founded: 2012
Entity Type: Private
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 2600 Hilltop Drive Building B, Suite C328 Richmond, California 94806 U.S. Tel. +1-510-708-0096 www.alstembio.com

Company Overview

ALSTEM is a biotech company based in the San Francisco Bay Area; it specializes in iPSC reprogramming technology and related products. ALSTEM was founded in 2012 by a team of scientists with expertise in iPSC reprogramming and genome editing technologies. ALSTEM’s iPSC-related products include iPSC reprogramming kits, human iPSC lines, isogenic iPSC lines, mouse iPSC lines, and culture media.

The company’s state-of-the-art facility houses full-service R&D laboratories and BSL-2 lab services to support its customers’ growing needs in genome editing, virus packaging, cell immortalization, and iPS technology. ALSTEM provides iPS technology under its license with iPS Academia Japan. The alliance allows the company to utilize the iPSC patent portfolio based on the discoveries of Dr. Shinya Yamanaka.

ALSTEM In Reports

Induced Pluripotent Stem Cells: Global Markets

BCC Research Market Report says global market for induced pluripotent stem cells is expected to grow from $3.4 billion in 2023 and forecast to reach $5.2 billion by the end of 2028 at a CAGR of 9.1%.

Induced Pluripotent Stem Cells: Global Markets

BCC Research Market Report says induced pluripotent stem cells should grow from $2.8 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate of 9.3%.

Induced Pluripotent Stem Cells: Global Markets

The global induced pluripotent stem cells (iPSC) market should reach $3.8 billion by 2024 from $2.4 billion in 2019 at a compound annual growth rate (CAGR) of 9.2% for the forecast period of 2019 to 2024. ...

View All Reports

ALSTEM In News

Stem cell-based therapy for human diseases - Signal Transduction and Targeted Therapy - Nature

Nature - Aug 06, 2022

Local students attend Birmingham’s first STEM Goes Red - www.heart.org

www.heart.org - Dec 01, 2022

The Differentiation Stage of Transplanted Stem Cells Modulates Nerve Regeneration - Nature

Nature - Dec 12, 2017

Let's get physic-al! STEM event encourages pupils to pursue physics - Inverness Courier

Inverness Courier - Oct 09, 2019

Company's Business Segments

  • Products : Cell Line Generation Tools, Cell Lines, Gene Editing, iPS Cell Lines, SARS-CoV-2 Related Products, Virus Packaging Tools, Cell Analyzing Tools.
  • Services : iPSC Generation, Gene Editing, Virus Packaging, Cell Line Generation, Cell Immortalization, Custom Solutions.

Applications/End User Industries

  • Biotechnology
  • Pharmaceutical
  • Research Institutes
  • Government Agencies
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment